Could indigo light help fight the growing “myopia boom?”
Share on Pinterest Recent research in tree shrews found that using indigo light indoors could help prevent myopia. Edwin Tan,…
Category: News
Breaking health news, medical updates, policy changes, and public health developments from around the world. We deliver timely, accurate health journalism to keep you informed and aware.
Obesity treatment should focus on better health, not weight loss alone
Share on Pinterest The Endocrine Society emphasizes that obesity treatment should focus on health outcomes, not just the number on…
More data, more answers? A 1.9 million-person health study shows why scale has limits
One of the world’s largest health cohorts provides researchers with an unusually detailed view of disease across Britain, but comparisons…
APOE genotype helps p-tau217 predict who may develop cognitive impairment sooner
A pooled analysis across seven multiethnic cohorts examines whether the same p-tau217 reading carries the same prognostic meaning for people…
A study of ayahuasca users found a mental health pattern researchers cannot yet explain
Researchers compared first-time and experienced ayahuasca users to see how prior exposure relates to mood, stress, spirituality, substance use, and…
Cockroaches have a reputation for surviving almost anything, but this diet proved deadly
What happens when an urban-adapted insect is fed a diet built around chips and candy? A controlled experiment offers a…
A large US study found no overall link between fluoride in pregnancy and children’s behavior
Researchers tracked prenatal exposure to public-water fluoride across 34 US states to examine whether concentrations during pregnancy were associated with…
NT-proBNP blood marker may help identify older adults at higher risk of heart disease
Share on Pinterest A NT-proBNP blood test could help indicate an increased risk of heart disease in older adults, according…
Subcutaneous tarlatamab exhibits low toxicity rates in phase 1b trial
Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with previously treated extensive-stage small cell…
Phase 2 study highlights flexible dosing options for tarlatamab in relapsed SCLC
Extended-interval dosing regimens of tarlatamab demonstrated efficacy, safety and pharmacokinetic profiles generally consistent with the established every-two-week regimen in patients…